Tong Nyu-Xia, Zhao Ying-Ying, Jin Xiu-Ming
Eye Center, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang Province, China; Zhejiang Provincal Key Lab of Ophthalmology, Hangzhou 310009, Zhejiang Province, China.
Int J Ophthalmol. 2016 Feb 18;9(2):282-5. doi: 10.18240/ijo.2016.02.20. eCollection 2016.
To evaluate the effectiveness of the Crawford tube in treating symptomatic epiphora without nasolacrimal obstruction.
A protocol was adopted for the management of symptomatic epiphora without nasolacrimal obstruction. Patients who suffered symptomatic epiphora without nasolacrimal obstruction in both eyes were included in the study. One eye was treated with Crawford tube intubation and the other eye was treated with medication therapy. Degree of watering, patient satisfaction, and symptomatic improvement were carefully evaluated by one of the authors at the end of the follow-up period, after Crawford tube removal, to ascertain functional results.
Thirty-seven adult patients (37 eyes) underwent Crawford tube intubation for functional epiphora. The mean follow-up time after removal of the tube was 14.8±4.8mo. The procedure was an overall success in 28 eyes (75.7%), with symptoms improving significantly. Two eyes (5.4%) were relieved of indoor epiphora, two (5.4%) had minimal epiphora outdoors, but only with wind or cold, and five (13.5%) continued to experience tearing both indoors and outdoors. Thirty of the patients (81%) expressed satisfaction with the procedure.
Crawford tube insertion is an effective, safe, simple, and relatively noninvasive treatment strategy for functional lacrimal system obstruction.
评估Crawford管治疗无鼻泪管阻塞的症状性溢泪的有效性。
采用一种治疗无鼻泪管阻塞的症状性溢泪的方案。纳入双眼有无鼻泪管阻塞的症状性溢泪患者。一只眼采用Crawford管插管治疗,另一只眼采用药物治疗。在随访期末、拔除Crawford管后,由一名作者仔细评估流泪程度、患者满意度和症状改善情况,以确定功能结果。
37例成年患者(37只眼)因功能性溢泪接受了Crawford管插管治疗。拔管后的平均随访时间为14.8±4.8个月。该手术在28只眼(75.7%)总体成功,症状明显改善。2只眼(5.4%)室内溢泪缓解,2只眼(5.4%)室外仅在有风或寒冷时轻度溢泪,5只眼(13.5%)室内外均持续流泪。30例患者(81%)对该手术表示满意。
插入Crawford管是治疗功能性泪道系统阻塞的一种有效、安全、简单且相对无创的治疗策略。